文献速递精神分裂症与精神病性障碍

预防临床高风险人群精神病发作:世界精神病学协会预防精神病学分会的一项更新版荟萃分析

Preventing psychosis in people at clinical high risk: an updated meta-analysis by the World Psychiatric Association Preventive Psychiatry section.
PubMed 文献 · Mol Psychiatry · 2025-02-14

该更新版系统综述与荟萃分析纳入24项随机对照试验、共3236例临床高风险精神病(CHR-P)个体,评估多种预防干预对精神病转化、症状严重程度和功能的影响。结果显示,与对照干预相比,所研究的主动干预均未对任何结局产生持续且稳健的效果,包括12个月时CBT对精神病转化的影响(9项RCT;OR 0.64;95%CI 0.39-1.06;I²=21%;P=0.08)。结果提示CHR-P领域需要新的治疗策略,未来研究应考虑该人群的异质性并优先采用分层策略和定制化治疗。

要点

  • 24项RCT、3236例CHR-P个体;主动干预对精神病转化等结局均无持续稳健效果。
  • 12个月时CBT对精神病转化:9项RCT,OR 0.64(95%CI 0.39-1.06),I²=21%,P=0.08。
  • 作者指出需新的治疗策略,未来研究应优先分层策略和定制化治疗。

核心结论

  • 与对照干预相比,所研究的任何主动干预均未对CHR-P个体任何调查结局产生持续且稳健的效果。
  • 这些结果突出表明CHR-P需要新的治疗方法。
  • 未来研究应考虑该临床人群的异质性,并优先采用分层策略和定制化治疗。

研究设计与样本

  • 遵循PRISMA指南和预注册方案,检索从建库至2023年11月。
  • 纳入收集CHR-P精神病转化(主要结局)数据的随机对照试验(RCT)。
  • 次要结局为症状严重程度和功能;调查时间点为6、12、24、36和+36个月。
  • 共纳入24项RCT、3236例CHR-P个体;使用OR和SMD作为汇总结局,异质性用Higgins I²估计。

主要发现

  • 主动干预包括CBT、家庭聚焦治疗、整合心理治疗、抗精神病药、omega-3脂肪酸、CBT联合利培酮、米诺环素及其他非药物方法(认知矫正、睡眠靶向治疗、脑刺激)。
  • 12个月时CBT对精神病转化:9项RCT,OR 0.64(95%CI 0.39-1.06),I²=21%,P=0.08。
  • 与对照干预相比,所研究的主动干预均未对任何调查结局显示持续且稳健的效果。

关键数值与推荐

  • 12个月时CBT对精神病转化:9项RCT,OR 0.64(95%CI 0.39-1.06),I²=21%,P=0.08。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recently published large-scale randomised controlled trials (RCTs) have questioned the efficacy of preventive interventions in individuals at clinical high risk for psychosis (CHR-P). We conducted a systematic review and meta-analysis to include this new evidence and provide future directions for the field. We followed the PRISMA guidelines and a pre-registered protocol, with a literature search conducted from inception to November 2023. We included RCTs that collected data on psychosis transition (the primary outcome) in CHR-P. Secondary outcomes were symptoms severity and functioning. Investigated time points were 6,12,24,36, and +36 months. We used odd ratios (ORs) and standardised mean differences (SMD) as summary outcomes. Heterogeneity was estimated with the Higgins I2. Twenty-four RCTs, involving 3236 CHR-P individuals, were included. Active interventions were Cognitive Behavioural Therapy (CBT), family-focused therapy, Integrated Psychological Therapy, antipsychotics, omega-3 fatty acids, CBT plus risperidone, minocycline, and other non-pharmacological approaches (cognitive remediation, sleep-targeted therapy, brain stimulation). Results showed no evidence that any of the investigated active interventions had a sustained and robust effect on any of the investigated outcomes in CHR-P, when compared to control interventions, including CBT on transition to psychosis at 12 months (9 RCTs; OR: 0.64; 95% CI: 0.39-1.06; I2: 21%; P = 0.08). These results highlight the need for novel treatment approaches in CHR-P. Future studies should consider the heterogeneity of this clinical population and prioritise stratification strategies and bespoke treatments.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Minichino A, Davies C, Karpenko O, et al. Preventing psychosis in people at clinical high risk: an updated meta-analysis by the World Psychiatric Association Preventive Psychiatry section. Mol Psychiatry. 2025. PMID: 39953286. doi:10.1038/s41380-025-02902-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。